Integra Lifesciences Holdings (IART) EBT Margin (2009 - 2026)
Integra Lifesciences Holdings (IART) posted EBT Margin of 1.13% for Q2 2026, up 284.3% sequentially from 0.61% in Q1 2026, and up 12889.0% YoY from N/an in Q2 2025.
Integra Lifesciences Holdings (IART) EBT Margin (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings has reported EBT Margin for 18 years, with the latest figure at 1.13% in Q2 2026.
- Quarterly EBT Margin rose 12889.0% year-over-year to 1.13% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.01% (up 3445.0% YoY) and the FY2025 annual result came in at 34.46%, down 3333.0% from the prior year.
- EBT Margin advanced to 1.13% in Q2 2026 per IART's latest filing, from 0.61% in the prior quarter.
- Over five years, EBT Margin peaked at 16.13% in Q4 2022 and troughed at 127.75% in Q2 2025.
- A 5-year average of 3.63% and a median of 1.07% in 2023 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2025 and 2026: EBT Margin slumped 12412 bps in 2025, then surged 12889 bps in 2026.
- Over 5 years, EBT Margin stood at 16.13% in 2022, then plunged by 55 bps to 7.27% in 2023, then decreased by 30 bps to 5.09% in 2024, then sank by 81 bps to 0.99% in 2025, then climbed by 14 bps to 1.13% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 1.13%, 0.61%, and 0.99% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 12.10% |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 23.74% |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 19.48% |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 29.86% |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 24.27% |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 13.09% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 8.91% |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 18.32% |
| 10 | Integra Lifesciences Holdings | 1.32 Bn | 1.05 Bn | 219.74 Mn | 1.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.13% |
| Mar 31, 2026 | -0.61% |
| Dec 31, 2025 | 0.99% |
| Sep 30, 2025 | -1.70% |
| Jun 30, 2025 | -127.75% |
| Mar 31, 2025 | -7.85% |
| Dec 31, 2024 | 5.09% |
| Sep 30, 2024 | -5.35% |
| Jun 30, 2024 | -3.63% |
| Mar 31, 2024 | -1.42% |
| Dec 31, 2023 | 7.27% |
| Sep 30, 2023 | 4.87% |
| Jun 30, 2023 | 1.00% |
| Mar 31, 2023 | 7.82% |
| Dec 31, 2022 | 16.13% |
| Sep 30, 2022 | 15.26% |
| Jun 30, 2022 | 12.96% |
| Mar 31, 2022 | 10.44% |
| Dec 31, 2021 | 12.77% |
| Sep 30, 2021 | 13.13% |